medigraphic.com
Colegio de Medicina Interna de México.

2005, Número 5

<< Anterior Siguiente >>

Med Int Mex 2005; 21 (5)


Neumonía nosocomial por Pseudomonas aeruginosa

Farías CE, Medina CRH, Chavarría GJ

Idioma: Español
Referencias bibliográficas: 36
Paginas: 368-379
Archivo PDF: 168.91 Kb.


RESUMEN

La neumonía por Pseudomonas aeruginosa es una infección nosocomial que a menudo se asocia con alta mortalidad. A esto contribuyen factores de predisposición del huésped y propios de la bacteria, mismos que se mencionan en esta revisión bibliográfica. Las claves para mejorar el pronóstico de los pacientes son el diagnóstico oportuno y un tratamiento agresivo.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Romero CR. Microbiología y parasitología humana. Bases etiológicas de las enfermedades infecciosas. 2ª ed. México: Médica Panamericana, 1999;pp:332-5.

  2. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC. Diagnóstico microbiológico. Texto y atlas a color. 5ª ed. Buenos Aires: Médica Panamericana, 1999.

  3. Palleroni NJ. Family I. Pseudomonadaceae. In: Krieg NR, Holt JG, editors. Bergey’s manual of systematic bacteriology. Baltimore: Williams & Wilkins, 1984.

  4. Gilardi GL. Pseudomonas and related genera. In: Balows A, editor. Manual of clinical microbiology. 5th ed. Washington: American Society for Microbiology, 1991;pp:429-41.

  5. Forkner CE. Pseudomonas aeruginosa infections. In: Wright IS, editor. Modern Medical Monographs No. 22. New York: Grune and Stratton, 1960;pp:1-5.

  6. Foca M, Jakob K, Whittier S, et al. Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit. N Engl J Med 2000;343:695-700.

  7. Rello J, Jubert P. Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis 1996;23:973-8.

  8. Hall Z. Pseudomonas infection caused by bronchoscope manufacturing defects: effective national recall procedures are needed. Thorax 2003;58(4):332.

  9. Walberg M, Brantsaeter AB, Lingaas E. Outbreak of hospital-acquired monoclonal Pseudomonas aeruginosa infection associated with the use of contaminated commercial mouth swabs in a primary and tertiary care hospital in Norway. Clin Mic Inf 2003;Suppl 9(Suppl 1):367-8.

  10. Becks VE, Lorenzoni NM. Pseudomonas aeruginosa outbreak in a neonatal intensive care unit: a possible link to contaminated hand lotion. Am J Infect Control 1995;23:396-8.

  11. Richards MJ, Edwards JR, Culver DH, et al. Nosocomial infections in medical intensive care units in the United States. Crit Care Med 1999;27:887-93.

  12. Weber DJ, Rutala WA, Mayhall CG. Nosocomial respiratory tract infections and gram-negative pneumonia. In: Fishman AP, editor. Fishman’s pulmonary diseases and disorders. 3rd ed. New York: McGraw-Hill, 1998;pp:2213-33.

  13. Craven DE, Steger KA. Epidemiology of nosocomial pneumonia: new perspectives on an old disease. Chest 1995;108:1S-16S.

  14. Tablan OC, Anderson LJ, Arden NH, and the Hospital Infection Control Practices Advisory Committee. Guideline for prevention of nosocomial pneumonia. Infect Control Hosp Epidemiol 1994;15:587-627.

  15. Levine SA, Niederman MS. The impact of tracheal intubation on host defenses and risks for nosocomial pneumonia. Clin Chest Med 1991;12:523-43.

  16. Weber DJ, Rutala WA. Nosocomial infections associated with respiratory therapy. In: Mayhall CG, editor. Hospital Epidemiology and Infection Control. Baltimore: Williams & Wilkins, 1996;pp:748-58.

  17. Craven DE, Steger KA. Nosocomial pneumonia in mechanically ventilated adult patients: epidemiology and prevention in 1996. Semin Respir Infect 1996;11:32-53.

  18. George DL. Epidemiology of nosocomial pneumonia in intensive care patients. Clin Chest Med 1995;16:29-44.

  19. Doig P, Todd T. Role of pili in adhesion of Pseudomonas aeruginosa to human respiratory epithelial cells. Infect Immun 1988;56:1641-6.

  20. Stratton CW. Pseudomonas aeruginosa revisited. Infect Control Hosp Epidemiol 1990;11:101-4.

  21. Quinn J. Pseudomonas aeruginosa infections in the intensive care unit. In: Clark N, Lynch J, editors. Semin Respir Crit Care Med 2003;24(1):61-68.

  22. Murray P, Kobayashi G, Pfaller M, Rosenthal K. Diagnóstico de laboratorio de las enfermedades bacterianas. Pseudomonas y bacterias no fermentadoras relacionadas. Microbiología médica. 2a ed. Madrid: Harcourt Brace, 1997.

  23. Roa J, Bermúdez M, Acero R. Enfermedades infecciosas. Neumología. Bogotá: McGraw-Hill Interamericana, 2000.

  24. Lynch J. Hospital-acquired pneumonia. Risk factors, microbiology, and treatment. Chest 2001;119(2):373S-84.

  25. Singh N, Rogers P, Atwood CW, et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000;17:791-801.

  26. Meduri GU, Johanson GW. International Consensus Conference: clinical investigation of ventilator-associated pneumonia. Chest 1992;102:551S-2.

  27. Fagon JY, Chastre J, Wolff M, et al. Invasive and non-invasive strategies for management of suspected ventilator-associated pneumonia. Ann Intern Med 2000;132:621-30.

  28. De Rosa FG, Craven DE. Ventilator-associated pneumonia: current management strategies. Infect Med 2003;20(5):248-59.

  29. Rello J, Paiva JA, Baraibar J, et al. International conference for the development of consensus on the diagnosis and treatment of ventilator-associated pneumonia. Chest 2001;120:955-70.

  30. Fink MP, Snydman DR, Niederman MS, et al. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. Antimicrob Agents Chemother 1994;35:547-57.

  31. Joshi M, Bernstein J, Solomkin J, Wester BA, Kuye O. Piperacillin-tazobactam plus tobramycin versus ceftazidime plus tobramycin for the treatment of patients with nosocomial lower respiratory tract infection. Piperacillin-tazobactam Nosocomial Pneumonia Study Group. J Antimicrob Chemother 1999;43:389-97.

  32. Mandell GL, Petri WA. Penicilinas, cefalosporinas y otros antibióticos b-lactámicos. En: Goodman y Gilman, editores. Las bases farmacológicas de la terapéutica. 9ª ed. México: McGraw-Hill Interamericana, 1997.

  33. Palmieri OJ. Enfermedades infecciosas. Chile: McGraw-Hill Interamericana, 2001.

  34. Crouch S, Wunderink RG, Jones CB, Leeper KV. Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest 1996;109:1019-29.

  35. Erwin AL, VanDevanter DR. The Pseudomonas aeruginosa genome: how do we use it to develop strategies for the treatment of patients with cystic fibrosis and Pseudomonas infections? Curr Opin Pulm Med 2002;8(6):547-51.

  36. Holder IA. Pseudomonas vaccination and immunotherapy: an overview. J Burn CareRehabil 2001;22(5):311-20.




2020     |     www.medigraphic.com